文献速递心律失常瓣膜病与结构性心脏病

经右心房穿刺左室行室速消融在双机械瓣患者中的 outcomes

Outcomes of Percutaneous Trans-Right Atrial Access to the Left Ventricle for Catheter Ablation of Ventricular Tachycardia in Patients With Mechanical Aortic and Mitral Valves.
PubMed 文献 · JAMA Cardiol · 2021-01-01

本观察性研究纳入4例主动脉瓣和二尖瓣均为机械瓣、反复发作单形性药物难治性室速且伴左室基质患者,采用经股静脉途径穿刺右心房下内侧(邻近左室下间隔突)在腔内超声引导下建立医源性 Gerbode 缺损进入左室行导管消融。结果显示该入路可行且安全,无入路相关并发症,3例达程序刺激下室速不可诱发,中位随访14个月无室速复发。

要点

  • 双机械瓣患者经股静脉穿刺右心房下内侧至左室下间隔突可建立左室入路。
  • 该入路在4例患者中可行且安全,无入路相关并发症及新发传导异常。
  • 3例达室速不可诱发,中位随访14个月无复发。

核心结论

  • 经右心房穿刺左室下间隔突的经皮入路在双机械瓣患者中行室速消融可行且初步安全。
  • 该技术可能为常规逆行主动脉或心房穿间隔途径不可行的患者提供消融选择。

研究设计与样本

  • 观察性研究,纳入连续4例主动脉瓣和二尖瓣均为机械瓣、反复单形性药物难治性室速伴左室基质患者。
  • 经股静脉途径,在腔内超声引导下穿刺右心房下内侧(邻近左室下间隔突)建立医源性 Gerbode 缺损,导丝进入左室后用直径8至10 mm非顺应性球囊扩张以利鞘管通过。
  • 平均(SD)年龄60(7)岁,平均(SD)左室射血分数31%(9%);缺血性心肌病3例,非缺血性心肌病1例。

主要发现

  • 获得左室入路时间从首例60分钟缩短至末例22分钟,平均(SD)36(15)分钟。
  • 无入路相关并发症;基线房室传导保留的3例患者入路后未观察到新发传导异常。
  • 3例在程序心室刺激下达到完全室速不可诱发,中位随访14个月(范围6-21个月)无患者室速复发。

临床怎么用

  • 对于主动脉瓣和二尖瓣均为机械瓣、常规逆行主动脉或心房穿间隔途径不可行的室速患者,可考虑经右心房穿刺左室下间隔突入路。
  • 操作需在腔内超声引导下进行,并使用可调弯鞘和射频导丝,球囊扩张后送入鞘管。

局限性

  • 样本量仅4例,属观察性研究,可行性与安全性需更大样本验证。
  • 随访时间中位14个月,长期疗效与安全性未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: In patients with mechanical valves in the aortic and mitral positions, percutaneous access to the left ventricle (LV) via a transfemoral approach for catheter ablation of ventricular tachycardia (VT) has been considered infeasible. OBJECTIVE: To describe the outcomes of a novel percutaneous trans-right atrial (RA) access to the LV via a femoral venous approach for catheter ablation of VT in patients with mechanical aortic and mitral valves. DESIGN, SETTING, AND PARTICIPANTS: This observational study included consecutive patients with mechanical valves in the aortic and mitral positions and recurrent monomorphic drug-refractory VT associated with an LV substrate. Percutaneous LV access was performed from a transfemoral venous route with the aid of a deflectable sheath and a radiofrequency wire by creating an iatrogenic Gerbode defect with direct puncture of the inferior and medial aspect of the RA, adjacent to the inferior-septal process of the LV (ISP-LV), under intracardiac echography guidance. Once the wire crossed to the LV, balloon dilatation of the ventriculotomy site (with a noncompliant balloon; diameter, 8 to 10 mm) was performed to facilitate passage of the sheath within the LV. EXPOSURES: Percutaneous trans-RA access to the LV via puncture of the ISP-LV to perform catheter ablation of VT in patients with mechanical aortic and mitral valves. MAIN OUTCOMES AND MEASURES: Feasibility and safety of a trans-RA access to the LV for catheter ablation of VT. RESULTS: A total of 4 patients (mean [SD] age, 60 [7] years; mean [SD] LV ejection fraction, 31% [9%]) with recurrent VT associated with an LV substrate (ischemic cardiomyopathy, 3 patients; nonischemic cardiomyopathy, 1 patient) and mechanical valves in the aortic and mitral position underwent trans-RA access through the ISP-LV for catheter ablation of VT. The time to obtain LV access ranged from 60 minutes (first case) to 22 minutes (last case) (mean [SD], 36 [15] minutes). No complications associated with the access occurred. In particular, in the 3 patients with preserved atrioventricular conduction at baseline, no new conduction abnormalities were observed after the access. Complete VT noninducibility at programmed ventricular stimulation was achieved in 3 cases, and no patient had VT recurrence at a median follow-up of 14 months (range, 6-21 months). CONCLUSIONS AND RELEVANCE: A percutaneous trans-RA access to the LV via a femoral venous approach for catheter ablation of VT in patients with mechanical aortic and mitral valves is feasible and appears safe. This novel technique may allow for catheter ablation of VT in a population of patients in whom conventional LV access via retrograde aortic or atrial transseptal routes is not possible.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Santangeli P, Hyman MC, Muser D, et al. Outcomes of Percutaneous Trans-Right Atrial Access to the Left Ventricle for Catheter Ablation of Ventricular Tachycardia in Patients With Mechanical Aortic and Mitral Valves. JAMA Cardiol. 2021. PMID: 32997112. doi:10.1001/jamacardio.2020.4414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。